KKAMG
COLL icon

Kernodle & Katon Asset Management Group’s Collegium Pharmaceutical COLL Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$2K Hold
150
– – ﹤0.01% 279
2016
Q4 		$2K Hold
150
– – ﹤0.01% 276
2016
Q3 		$3K Hold
150
– – ﹤0.01% 320
2016
Q2 		$2K Buy
150
+125
+500% +$2.06K ﹤0.01% 285
2016
Q1 		$0 Buy
25
+10
+67% +$182 ﹤0.01% 318
2015
Q4 		$0 Buy
+15
New +$316 ﹤0.01% 267

Other funds holding COLL

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kernodle & Katon Asset Management Group's COLL Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group held its Collegium Pharmaceutical (COLL) position steady in Q1 2017 at 150 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #279.

Kernodle & Katon Asset Management Group first reported a position in COLL in Q4 2015 and has held it in 6 quarters since. The position peaked at $3K in Q3 2016. 83 funds tracked by Wall St. Rank hold COLL as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 150 shares of Collegium Pharmaceutical worth $2K as of Q1 2017.
  • Kernodle & Katon Asset Management Group left its Collegium Pharmaceutical share count unchanged in Q1 2017.
  • Collegium Pharmaceutical made up ﹤0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #279 holding.
  • Kernodle & Katon Asset Management Group first reported a position in Collegium Pharmaceutical in Q4 2015 and has held it in 6 quarters since.
  • Kernodle & Katon Asset Management Group's Collegium Pharmaceutical position peaked at $3K in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.